-
Atiprimod (INN,
codenamed SK&F106615) is a
substance being studied in the
treatment of
certain multiple myelomas and
other advanced cancers. It may block...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
-
Oclacitinib Peficitinib Ruxolitinib Tofacitinib (tasocitinib)
Upadacitinib JAK2
Atiprimod AZD-1480
Baricitinib CHZ868
Cucurbitacin I (elatericin B, JSI-124) CYT387...
